MedTrace Logo

Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction

NCT00712894 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2012-09-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of three different vasodilators including diltiazem, verapamil and nitroglycerin for reversal of no-reflow/slow-flow during direct percutaneous coronary intervention for acute myocardial infarction.

Conditions

  • Acute Myocardial Infarction
  • Percutaneous Coronary Intervention

Interventions

DRUG

Diltiazem

Intracoronary Infusion 400-2000ug

DRUG

Verapamil

Intracoronary Infusion 200-1000ug

DRUG

Nitroglycerin

Intracoronary Infusion 200-1000ug

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Junbo Ge, M.D. · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-04-30
Completion
2009-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00712894 on ClinicalTrials.gov